Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jul;24(7):431-8.
doi: 10.1038/jhh.2010.37. Epub 2010 Apr 8.

Determining which automatic digital blood pressure device performs adequately: a systematic review

Affiliations

Determining which automatic digital blood pressure device performs adequately: a systematic review

Y Wan et al. J Hum Hypertens. 2010 Jul.

Abstract

The aim of this study is to systematically examine the proportion of accurate readings attained by automatic digital blood pressure (BP) devices in published validation studies. We included studies of automatic digital BP devices using recognized protocols. We summarized the data as mean and s.d. of differences between measured and observed BP, and proportion of measurements within 5 mm Hg. We included 79 articles (10,783 participants) reporting 113 studies from 22 different countries. Overall, 25/31 (81%), 37/41 (90%) and 34/35 (97%) devices passed the relevant protocols [BHS, AAMI and ESH international protocol (ESH-IP), respectively]. For devices that passed the BHS protocol, the proportion of measured values within 5 mm Hg of the observed value ranged from 60 to 86% (AAMI protocol 47-94% and ESH-IP 54-89%). The results for the same device varied significantly when a different protocol was used (Omron HEM-907 80% of readings were within 5 mm Hg using the AAMI protocol compared with 62% with the ESH-IP). Even devices with a mean difference of zero show high variation: a device with 74% of BP measurements within 5 mm Hg would require six further BP measurements to reduce variation to 95% of readings within 5 mm Hg. Current protocols for validating BP monitors give no guarantee of accuracy in clinical practice. Devices may pass even the most rigorous protocol with as few as 60% of readings within 5 mm Hg of the observed value. Multiple readings are essential to provide clinicians and patients with accurate information on which to base diagnostic and treatment decisions.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flowchart of search results.
Figure 2
Figure 2
Means and s.d. of errors in systolic BP in devices passing, or failing (marked dagger), the British Hypertension Society protocol.
Figure 3
Figure 3
Means and s.d. of errors in systolic BP in devices passing, or failing (marked dagger), the AAMI protocol.
Figure 4
Figure 4
Means and s.d. of errors in systolic BP in devices passing, or failing (marked dagger), the ESH-IP protocol.
Figure 5
Figure 5
Mean and single s.d. of errors in BP monitors in repeated studies of the same monitor.

Similar articles

Cited by

References

    1. O'Brien E, Asmar R, Beilin L, Imai Y, Mallion JM, Mancia G, et al. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens. 2003;21 (5:821–848. - PubMed
    1. Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense HW, Joffres M, et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA. 2003;289 (18:2363–2369. - PubMed
    1. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jr, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289 (19:2560–2572. - PubMed
    1. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT) JAMA. 2002;288 (23:2981–2997. - PubMed
    1. Julius S, Jamerson K, Gudbrandsson T, Schork N. White coat hypertension: a follow-up. Clin Exp Hypertens A. 1992;14 (1–2:45–53. - PubMed

Publication types